Chapter 5 128 identified i.e., diagnosed, but this is not feasible. Even with high dementia prevalence (e.g., including the severe or known demented, although not the clinical reality), the PPV of this extra cut-off would increase but never to the needed PPV of 100%. For settings similar to ours, we recommend the use of the double threshold as described of <21 and ≥26, as these cut-offs give the best results, including the Youden index (Dautzenberg et al., 2020, 2021). This corresponds with the most error-prone scores of the MoCA (Landsheer, 2020) and is consistent with another study in old-age psychiatry, in which 87% of patients with dementia scored <20 and 100% scored <23 on the MoCA (Korsnes, 2020). In addition, almost all MCI patients with low MoCA scores (<20) will develop MD whereas only half of the MCI patient above this score will convert in the near future (Julayanont et al., 2014). Another study showed that 65% of their MCI patients with a score <26 did not convert to MD (Smith et al., 2007). This suggests that a doublethreshold MoCA can separate low-risk MCI patients from very high-risk patients along with almost all patients with MD and benefit from a specialised diagnostic route. Although our findings are not compatible with other settings, different settings may also benefit from a double-threshold MoCA. Whether it is to improve accuracy or because these settings have a more diverse population (and less uniformly distributed cognitive functioning). Even if one does not agreewith our proposed policy because of a lowprevalence of psychiatric diseases or easy access to specialised diagnostic routes in their setting. The 3 policies can easily be altered to fit once own setting, e.g., full memory clinic work up <21; 21< active monitoring with an NPA <26; and ≥26 watchful waiting with a MoCA. As the MoCA can detect changes over time in MCI patients (Krishnan et al., 2017) and remains stable among cognitively normal patients (Malek-Ahmadi et al., 2018), active monitoring (21<26) can be done by reassessment with a MoCA, which has three versions avoiding a learning curve (Costa et al., 2012; Nasreddine and Patel, 2016) and has a high retest reliability (Bruijnen et al., 2020). Together with an interview on IADL, giving an improved model fit (Durant et al., 2016) combined with an IQcode (De Jonghe, 1997), it can be administered in less than 30 minutes and could increase the overall diagnostic accuracy (Roalf et al., 2013). The average time of an NPA was 9 h, including processing and feedback, at a cost of (in the Netherlands) €110/h. Therefore, the MoCA can not only reduce the stressful NPA waiting list but also avoid €1000 per FP and actively monitor those at risk less expensively.
RkJQdWJsaXNoZXIy MTk4NDMw